Rj. Turesky et al., METABOLISM OF THE FOOD-BORNE MUTAGEN 2-AMINO-3,8-DIMETHYLIMIDAZO[4,5-F]QUINOXALINE IN HUMANS, Chemical research in toxicology, 11(3), 1998, pp. 217-225
The metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx
) was investigated in five human volunteers given a dietary equivalent
of C-14-labeled MeIQx. The amount of the dose excreted in urine range
d from 20.2% to 58.6%, with unmetabolized MeIQx accounting for 0.7-2.8
% of the dose. Five principal metabolites were detected in urine, and
four of the derivatives were characterized by on-line UV spectroscopy
and by HPLC-MS following immunoaffinity chromatography. Two metabolite
s were identified as the phase II conjugates 3,8-dimethylimidazo[4,5-f
]quinoxalin-2-yl)sulfamic acid (MeIQx-N-2-SO3-) and nyl)-2-amino-3,8-d
imethylimidazo[4,5-f]quinoxaline (MeIQx-N-2-Gl). Two other metabolites
were the cytochrome P450-mediated (P450) oxidation products 8(hydroxy
methyl)-3-methylimidazo[4,5-f]quinoxaline (8-CH2OH-MeIQx), and roxy-2-
amino-3,8-dimethylimidazo[4,5-f]quinoxaline (NOH-MeIQx-N-2-Gl). The la
tter product is a conjugate of the genotoxic metabolite ydroxyamino)-3
,8-dimethylimidazo[4,5-f]quinoxaline (NHOH-MeIQx). A large interindivi
dual variation was observed in the metabolism and disposition of MeIQx
; these four metabolites and unchanged MeIQx combined accounted for 6.
3-26.7% of the total dose. The remaining principal metabolite found in
all subjects accounted for 7.6-28% of the dose. It has not been previ
ously identified in rodents or nonhuman primates, and its structure re
mains unknown. P450-mediated ring oxidation of MeIQx at the C-5 positi
on, a major pathway of detoxication in rodents, was not detected in hu
mans. Both 8-CH2OH-MeIQx formation and NHOH-MeIQx formation are cataly
zed by P450 1A2 and may be useful biomarkers of P450 1A2 activity in h
umans. The levels of NHOH-MeIQx-N-2-Gl found in human urine ranged fro
m 1.4% to 10.0% of the dose, which is significantly higher than that f
ormed in rodents and nonhuman primates undergoing cancer bioassays. Th
us, bioactivation of MeIQx by P450-mediated N-oxidation is extensive i
n humans.